XML 68 R57.htm IDEA: XBRL DOCUMENT v3.19.1
Related Parties Transactions (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 12, 2017
May 06, 2016
Feb. 02, 2019
Nov. 29, 2018
Jun. 27, 2018
Jan. 18, 2018
Sep. 30, 2017
Sep. 28, 2017
Jul. 24, 2017
Jan. 26, 2017
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Aug. 25, 2018
May 09, 2018
Dec. 31, 2017
Related Parties Transactions (Textual)                                
Amount received from BriVision                     $ 7,594,784   $ 7,745,096     $ 4,229,320
Outstanding loan                     233,000   692,980      
Accrued interest                     11,971   281      
Interest expenses                     129,886 $ 106,854        
Common stock new issues                     694,219 80,000        
Additional paid-in capital                     15,680,674   14,983,714      
Related party transactions, description             Pursuant to the Investment and Equity Transfer Agreement, Everfront agreed to purchase 2,000,000 common shares of the Company owned by AsianGene at $1.60 per share in a total amount of $3,200,000, of which $160,000 is due before September 15, 2017 and the remaining amount of $3,040,000 is due before December 15, 2017. AsianGene also agreed to loan the proceeds to the Company for working capital purpose.                  
Yuangene Corporation [Member]                                
Related Parties Transactions (Textual)                                
Outstanding loan                     $ 926,395          
Related party transactions, description                     The advances bear 0% interest rate and are due on demand.          
Unsecured convertible promissory note [Member]                                
Related Parties Transactions (Textual)                                
Accrued interest                     $ 43,467   27,467      
Aggregate principal amount         $ 250,000                 $ 250,000 $ 300,000  
Chairman [Member]                                
Related Parties Transactions (Textual)                                
Outstanding loan                     157,140          
Accrued interest                     $ 10,454          
Related party transactions, description                     The advances bears interest at 1% per month (or equivalent to 12% per annum) and are due on demand.          
Collaborative Arrangement [Member]                                
Related Parties Transactions (Textual)                                
Amount received from BriVision                     $ 100,000,000          
Interest rate percentage                     0.00%          
Outstanding advance                     $ 517,949          
Common stock new issues   $ 900,000             $ 3,000,000              
Loan Agreement [Member]                                
Related Parties Transactions (Textual)                                
Total commitment     $ 693,000             $ 950,000            
Loan maturity date     Feb. 01, 2020                          
Loan agreement, description               BioLite Taiwan and BioFirst entered into three loan agreements for a total amount of NTD$27,800,000, equivalent to $900,720, to meet its working capital needs. Under the terms of the loan agreements, the loans bear interest at 1% per month (or equivalent to 12% per annum). BioLite Taiwan repaid NTD$7,500,000, equivalent to $243,000, of the loan in 2018. The remaining balance was NTD$20,300,000, equivalent to $657,720 with the interest rate and term remain unchanged. The three loans will be matured on September 27, 2019, October 30, 2019, and November 12, 2019, respectively.   The loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the Company is required to pay interest monthly to the lender.            
Outstanding loan                     657,720   663,810      
Accrued interest                     146,274   127,976      
Interest expenses                     19,472 28,500        
Loan Agreement [Member] | BriVision and BioFirst Agreement [Member]                                
Related Parties Transactions (Textual)                                
Interest expenses                     11,710 9,500        
Asiangene Corporation [Member]                                
Related Parties Transactions (Textual)                                
Outstanding loan                     160,000   160,000      
Accrued interest                     17,600   12,866      
Interest expenses                     $ 4,734 3,945        
Interest rate percentage                     0.00%          
Yuangene Corporation [Member]                                
Related Parties Transactions (Textual)                                
Outstanding loan                     $ 50,000   50,000      
Accrued interest                     7,200   5,721      
Interest expenses                     1,479 1,200        
Aggregate working capital           $ 50,000         $ 42,690   $ 42,690      
Interest rate percentage                     0.00%   0.00%      
Related party transactions, description           Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the Company is required to pay interest monthly to the lender. The maturity date of this loan is January 19, 2019.                    
Keypoint Technology Ltd [Member] | Unsecured convertible promissory note [Member]                                
Related Parties Transactions (Textual)                                
Amount received from BriVision         $ 250,000                      
Interest expenses                     $ 5,000 0        
Interest rate percentage         8.00%                      
Yoshinobu Odaira [Member] | Unsecured convertible promissory note [Member]                                
Related Parties Transactions (Textual)                                
Amount received from BriVision       $ 250,000                        
Interest expenses                     5,000 0        
Interest rate percentage       8.00%                        
Loan Agreement One [Member]                                
Related Parties Transactions (Textual)                                
Loan maturity date May 11, 2019                              
Loan agreement, description BioLite BVI and BioFirst entered into a loan agreement for NTD$30,000,000, equivalent to $972,000 to meet its working capital needs. Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum). BioLite BVI and BioFirst extended the loan with the same interest rate and amount for one year.                              
Outstanding loan                     972,000   $ 981,000      
Accrued interest                     250,771   $ 222,000      
Interest expenses                     $ 28,771 $ 29,978